BioMarin says FDA to delay deciding on approval of DMD drug
December 18, 2015 at 08:43 AM EST
Dec 18 (Reuters) - Drug developer BioMarin Pharmaceutical Inc said it was notified by the U.S. Food and Drug Administration that it would not be able to decide on the marketing of the company's lead drug as scheduled.
